Novo Nordisk A/S
Novo Nordisk A/S is a pharmaceutical company, created in 1989 by a merger
between Novo Industry A/S and Nordisk Gentofle A/S, specialized in the
medications for diabetes, like insulin.
The Novo Nordisk Foundation is a non-profit institution, whose bollock purpose
is to provide a stable basis for its companys trading operations and to make
contributions to scientific, humanitarian and social progress.
( explanation from the web site)
As mentioned preceding(prenominal) Novo Nordisk is specialized in diabetes care, and for this reason
became the world attractor in the diabetes care field.
This company has the nearly innovative ( thats what the Novo Nordisk claims) diabetes
cure products. For this reason the company is in like manner a leader in areas such as
haemostasis management, growth hormone therapy and hormone replacement
therapy.
Since it is a pharmaceutical company innovation is a fundamental, essential.
Improvement in the most important and ceaseless step in the company, to insure
the company leadership and to keep providing the latest medical care to its patients.
To provide the company correct function, Novo Nordisk have some policies to pick up its employees :
In Novo Nordisk we willing provide attractive, engaging and effective workplaces for our
This means that we:
-
create a diverse and inclusive workplace providing exist opportunities for all
-
are committed to the on-going development of our people
-
develop leaders who will drive the engagement and performance of our people
-
ensure effective and efficient work processes by applying global standards
-
offer mart competitive remuneration and employment conditions
-
offer a workplace that supports a healthy lifestyle
-
comply with legislation, relevant requirements and the UN Global Compact.
( one of the thirteen gravestone points policies, from the Novov Nordisk website)
From what we can teach the company have high expectations, because the patients
have high...
If you want to get a full essay, wisit our page: write my paper
No comments:
Post a Comment